Expression of C1q complement component in barrett's esophagus and esophageal adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 14, Issue 8, 2010, Pages 1207-1213

  Bobryshev, Yuri V ^a   Lu, Jinhua ^b   Lord, Reginald V N ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adenocarcinoma, C1q; Barrett's esophagus; Dendritic cells; Inflammation; Intestinal metaplasia

Indexed keywords

COMPLEMENT COMPONENT C1Q; RNA;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; BIOSYNTHESIS; COMPARATIVE STUDY; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; BLOTTING, WESTERN; COMPLEMENT C1Q; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 77954953010     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1230-y     Document Type: Article

References (32)

1. O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001; 85: 473-483.
2. Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004; 286: G515-520.
3. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008; 454: 436-444.
4. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226: 522-530.
5. Der R, Tsao-Wei DD, DeMeester T, et al. Carditis: a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001; 25: 245-252.
6. Moons LM, Kusters JG, Bultman E, et al. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 2005; 207: 269-276.
7. Abdel-Latif MM, Duggan S, Reynolds JV et al. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 2009; 9: 396-404.
8. Bobryshev YV, Tran D, Killingsworth MC et al. Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma. J Gastrointest Surg 2009; 13: 44-53.
9. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
10. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449; 419-426.
11. van de Ven R, Scheffer GL, Scheper RJ, et al. The ABC of dendritic cell development and function. Trends Immunol 2009; 30: 421-429.
12. Lotze MT, Thomson AW, eds. Dendritic cells: Biology and Clinical Applications, 2nd edn. San Diego, CA: Academic Press, 2001.
13. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002; 82; 97-130.
14. van Kooten C, Fiore N, Trouw LA, Csomor E, Xu W, Castellano G, Daha MR, Gelderman KA. Complement production and regulation by dendritic cells: molecular switches between tolerance and immunity. Mol Immunol 2008; 45: 4064-4072.
15. Lu J, Wu X, Teh BK. The regulatory roles of C1q. Immunobiology 2007; 212: 245-252.
16. Lu JH, Teh BK, Wang L, Wang YN, Tan YS, Lai MC, Reid KB. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol 2008; 5: 9-21.
17. Schwaeble W, Schafer M. K, Petry F, et al. Follicular dendritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J Immunol 1995; 155: 4971-4978.
18. Cook HT, Botto M. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006; 2: 330-337.
19. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 2007; 40: 560-566.
20. Lindau D, Decker P. Nph, DC and chromatin-mediated pathogenesis in systemic lupus erythematosus. Autoimmunity 2009; 42: 254-256.
21. Lechmann M, Zinser E, Golka A, Steinkasserer A. Role of CD83 in the immunomodulation of dendritic cells. Int Arch Allergy Immunol 2002; 129: 113-118.
22. Engering A, Geijtenbeek TB, van Vliet SJ, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002; 168: 2118-2126.
23. Cao W, Lee SH, Lu J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J 2005; 385(Pt 1): 85-93.
24. Bobryshev YV, Cao W, Phoon MC, Tran D, Chow VT, Lord RS, Lu J. Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesions. Atherosclerosis 2004; 173: 185-195.
25. Lu J, Zheng MH, Yan J, Chen YP, Pan JP. Effects of vasoactive intestinal peptide on phenotypic and functional maturation of dendritic cells. Int Immunopharmacol. 2008; 8: 1449-1454.
26. Kishore U, Reid K. B. C1q: structure, function, and receptors. Immunopharmacology 2000, 49: 159-170.
27. Reid K. B, Colomb M, Petry F, Loos M. Complement component C1 and the collectins-first-line defense molecules in innate and acquired immunity. Trends Immunol 2002; 23: 115-117.
28. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-569.
29. Botto M. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp Clin Immunogenet 1998; 15: 231-234.
30. Schaller M, Bigler C, Danner D, Ditzel HJ, Trendelenburg M. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven. J Immunol 2009; 183: 8225-8231.
31. Kaisho T. Type I interferon production by nucleic acid-stimulated dendritic cells. Front Biosci 2008; 13: 6034-6042.
32. Finke D, Eloranta ML, Rönnblom L. Endogenous type I interferon inducers in autoimmune diseases. Autoimmunity 2009; 42: 349-352.